In this month’s edition of the Journal of Nuclear Medicine, researchers published two separate studies illustrating how innovative PET imaging and radiopharmaceuticals may be used to help doctors learn more about breast cancer by targeting estrogen receptors. Read More
MITA released a report yesterday detailing the troubling impact of insurance coverage denials on patient access to medical imaging procedures. Data gathered by the Patient Advocacy Foundation (PAF) show that denials for patients seeking potentially life-saving medical imaging services have doubled in the past four years. Of even greater concern is the finding that 90 percent of the reversed denials for imaging services were actually covered by patients’ health plans. And on average, PAF’s professional case managers required 15.4 contacts per patient case to resolve the imaging issue, meaning it took on average more than 15 phone calls, letters or emails to determine why the imaging test was being denied coverage. Read More
Stay Informed
Sign up for news and information from MITA.
- Breast Cancer
- Chemotherapy
- Early Detection
- FDG
- FES
- Innovation
- JNM
- PET
- Radiopharmaceutical
- Research
- Treatment
No Comments